Product Information

CHOLESTYRAMINE PACKET is a generic product labeled by Endo USA Inc., priced at $0.9031 per EA under NDC 49884046565. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Aug 26, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CHOLESTYRAMINE PACKET

cholestyramine
$0.9031per EA

Strength

4 g/9g

Manufacturer

Endo USA Inc.

NDC

49884046565

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CHOLESTYRAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA077204

FDA Approved

8/26/2005

TE Code

AB

On Market Since

9/15/2005

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price Statistics

The NADAC for CHOLESTYRAMINE PACKET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 44.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9031 per EA
All-time high$1.9352 (May 13, 2015)
All-time low$0.5806 (Apr 17, 2024)
52-week high$0.9309
52-week low$0.6721
Median price$1.3500
Average price$1.3289
Largest weekly change+34.2% (Jun 19, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+8.3%

3M

+16.9%

6M

+13.5%

1Y

-3.8%

3Y

+33.4%

5Y

-21.1%

All

-44.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CHOLESTYRAMINE PACKET?

The current National Average Drug Acquisition Cost (NADAC) for CHOLESTYRAMINE PACKET, manufactured by Endo USA Inc., is $0.9031 per EA (NDC 49884046565), effective Nov 11, 2026.

How has the price of CHOLESTYRAMINE PACKET changed over time?

Over the history we have for it, the NADAC for CHOLESTYRAMINE PACKET has declined 44.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CHOLESTYRAMINE PACKET?

Since Nov 28, 2013, the NADAC for CHOLESTYRAMINE PACKET has ranged from a low of $0.5806 (Apr 17, 2024) to a high of $1.9352 (May 13, 2015), with a median of $1.3500 per EA.

Are there cheaper alternatives to CHOLESTYRAMINE PACKET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHOLESTYRAMINE LIGHT PACKET, is $0.8638 per EA — about 4% below CHOLESTYRAMINE PACKET.

Who manufactures CHOLESTYRAMINE PACKET?

CHOLESTYRAMINE PACKET (NDC 49884046565) is labeled by Endo USA Inc., and CMS classifies it as a generic product.